Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1.55
HKD
|
0.00%
|
|
+1.97%
|
+1.97%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,562
|
1,309
|
1,325
|
1,648
|
2,496
|
1,813
|
Enterprise Value (EV)
1 |
3,081
|
2,610
|
2,299
|
2,808
|
3,999
|
2,943
|
P/E ratio
|
9.17
x
|
7.08
x
|
4.86
x
|
5.5
x
|
6.03
x
|
1.49
x
|
Yield
|
5.42%
|
6.9%
|
8.51%
|
7.43%
|
6.83%
|
4.7%
|
Capitalization / Revenue
|
0.15
x
|
0.11
x
|
0.13
x
|
0.15
x
|
0.14
x
|
0.54
x
|
EV / Revenue
|
0.3
x
|
0.21
x
|
0.22
x
|
0.26
x
|
0.22
x
|
0.88
x
|
EV / EBITDA
|
4.98
x
|
4.66
x
|
3.79
x
|
3.5
x
|
4.17
x
|
20.2
x
|
EV / FCF
|
-9.22
x
|
5.41
x
|
4.35
x
|
-9.68
x
|
-9.9
x
|
4.52
x
|
FCF Yield
|
-10.8%
|
18.5%
|
23%
|
-10.3%
|
-10.1%
|
22.1%
|
Price to Book
|
0.52
x
|
0.46
x
|
0.45
x
|
0.48
x
|
0.66
x
|
0.41
x
|
Nbr of stocks (in thousands)
|
563,889
|
564,029
|
564,029
|
556,659
|
568,484
|
568,484
|
Reference price
2 |
2.770
|
2.320
|
2.350
|
2.960
|
4.390
|
3.190
|
Announcement Date
|
4/23/18
|
4/17/19
|
4/20/20
|
4/15/21
|
4/27/22
|
4/24/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
10,280
|
12,388
|
10,465
|
10,776
|
17,805
|
3,359
|
EBITDA
1 |
618.9
|
560.5
|
606.5
|
801.4
|
960
|
146
|
EBIT
1 |
419.5
|
377.2
|
474.4
|
625.6
|
775.8
|
-38.96
|
Operating Margin
|
4.08%
|
3.05%
|
4.53%
|
5.81%
|
4.36%
|
-1.16%
|
Earnings before Tax (EBT)
1 |
391
|
412.3
|
480.9
|
534.9
|
739.2
|
-64.12
|
Net income
1 |
170.6
|
184.8
|
272.9
|
302.6
|
406.3
|
1,218
|
Net margin
|
1.66%
|
1.49%
|
2.61%
|
2.81%
|
2.28%
|
36.26%
|
EPS
2 |
0.3020
|
0.3277
|
0.4839
|
0.5377
|
0.7278
|
2.142
|
Free Cash Flow
1 |
-334.1
|
482.1
|
529
|
-290.2
|
-403.8
|
650.5
|
FCF margin
|
-3.25%
|
3.89%
|
5.06%
|
-2.69%
|
-2.27%
|
19.37%
|
FCF Conversion (EBITDA)
|
-
|
86.02%
|
87.23%
|
-
|
-
|
445.48%
|
FCF Conversion (Net income)
|
-
|
260.86%
|
193.84%
|
-
|
-
|
53.41%
|
Dividend per Share
2 |
0.1500
|
0.1600
|
0.2000
|
0.2200
|
0.3000
|
0.1500
|
Announcement Date
|
4/23/18
|
4/17/19
|
4/20/20
|
4/15/21
|
4/27/22
|
4/24/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
1,519
|
1,302
|
974
|
1,161
|
1,504
|
1,130
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.454
x
|
2.322
x
|
1.605
x
|
1.448
x
|
1.566
x
|
7.737
x
|
Free Cash Flow
1 |
-334
|
482
|
529
|
-290
|
-404
|
650
|
ROE (net income / shareholders' equity)
|
7.77%
|
7.29%
|
9.64%
|
10.4%
|
12.8%
|
-1.68%
|
ROA (Net income/ Total Assets)
|
3.45%
|
2.88%
|
3.69%
|
4.83%
|
5.14%
|
-0.26%
|
Assets
1 |
4,945
|
6,423
|
7,397
|
6,265
|
7,902
|
-460,950
|
Book Value Per Share
2 |
5.280
|
5.030
|
5.220
|
6.120
|
6.690
|
7.750
|
Cash Flow per Share
2 |
1.680
|
2.370
|
1.790
|
1.020
|
1.330
|
1.910
|
Capex
1 |
181
|
236
|
261
|
190
|
521
|
186
|
Capex / Sales
|
1.76%
|
1.91%
|
2.49%
|
1.76%
|
2.92%
|
5.55%
|
Announcement Date
|
4/23/18
|
4/17/19
|
4/20/20
|
4/15/21
|
4/27/22
|
4/24/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.97% | 113M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|